GoodRx Holdings (GDRX) Cash from Investing Activities (2019 - 2026)

GoodRx Holdings' Cash from Investing Activities history runs 8 years deep, the most recent figure standing at -$21.6 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 58.28% year-over-year to -$21.6 million; the TTM figure through Mar 2026 stood at -$89.7 million (up 11.69% YoY), while the FY2025 annual figure was -$120.0 million, down 70.53% from the prior year.
• Cash from Investing Activities came in at -$21.6 million for Q1 2026 at GoodRx Holdings, up from -$31.8 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $1.3 million in Q4 2022 to a low of -$163.6 million in Q2 2022.
• A 5-year average of -$28.1 million and a median of -$17.2 million in 2024 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities soared 113.89% in 2022 and plunged 1100.93% in 2023, its largest moves.
• GoodRx Holdings' Cash from Investing Activities stood at $1.3 million in 2022, then slumped by 1100.93% to -$12.9 million in 2023, then decreased by 29.3% to -$16.6 million in 2024, then slumped by 90.88% to -$31.8 million in 2025, then soared by 31.87% to -$21.6 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$21.6 million, -$31.8 million, and -$18.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison